Podcast Episodes

Back to Search
142: How Microalgae Cuts Antibody Costs by 70% and Redefines Biomanufacturing with Muriel Bardor - Part 2

Episode 142

What if we could revolutionize biotechnology by slashing antibody production costs by 70%? In a world where traditional mammalian cell cultures strug…

1 year, 2 months ago

Short Long
View Episode
141: How Microalgae Cuts Antibody Costs by 70% and Redefines Biomanufacturing with Muriel Bardor - Part 1

Episode 141

The world of biologics manufacturing is about to be transformed by a breakthrough that slashes antibody production costs by 70%. This revolutionary a…

1 year, 2 months ago

Short Long
View Episode
140: Regulatory Secrets Revealed: Why Your CMC Strategy Could Make or Break Your Biotech Startup with Rivka Zaibel - Part 2

Episode 140

In this episode, we explore the important steps in preparing for regulatory meetings, address the dangers of cross-contamination in biotechnology fac…

1 year, 2 months ago

Short Long
View Episode
139: Regulatory Secrets Revealed: Why Your CMC Strategy Could Make or Break Your Biotech Startup with Rivka Zaibel - Part 1

Episode 139

In biotherapeutic drug development, the journey from discovery to clinic involves navigating a labyrinth of regulatory requirements and strategic con…

1 year, 2 months ago

Short Long
View Episode
138: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi Quint - Part 2

Episode 138

In the fast-evolving world of biotechnology, the pursuit of efficiency and faster development has never been more critical. The computational tools a…

1 year, 3 months ago

Short Long
View Episode
137: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi Quint - Part 1

Episode 137

The integration of AI into drug discovery has already led to groundbreaking advancements, uncovering patterns in vast datasets that were previously i…

1 year, 3 months ago

Short Long
View Episode
136: 5 Roadblocks to Affordable Biologics (And How to Overcome Them)

Episode 136

Sickle cell disease affects thousands with severe daily pain. While FDA-approved gene therapies exist, their $2.2 million cost per treatment makes th…

1 year, 3 months ago

Short Long
View Episode
135: Beyond Breakthroughs: Making Biotherapeutics Affordable for All

Episode 135

In a world of rapid advancements in medical science and biotechnology, bioprocessing is at the forefront of healthcare innovation. Yet, despite remar…

1 year, 3 months ago

Short Long
View Episode
134: Seamless Seed Trains: Simplify Without Sacrificing Quality with François Carruzzo - Part 2

Episode 134

The biotechnology industry is on a transformative path. With emerging technologies and innovative ideas, bioprocessing professionals are poised to re…

1 year, 3 months ago

Short Long
View Episode
133: Seamless Seed Trains: Simplify Without Sacrificing Quality with François Carruzzo - Part 1

Episode 133

Biologics manufacturing relies heavily on optimizing various stages, yet the seed train step - often overlooked - plays a critical role in determinin…

1 year, 3 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us